Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × Observation × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 4 Oropharyngeal Neoplasms 2 Breast Neoplasms 2 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Obesity 1 Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Helicobacter Infections 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Breast Carcinoma In Situ 1 Anus Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1 Anal Canal Carcinoma 1

Interventions

poly ICLC 1 pembrolizumab 1 atezolizumab 1 Specimen Handling 1 Sorafenib 1 Nivolumab 1 Irinotecan 1 Ipilimumab 1 DT2216 1 Cyclophosphamide 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡